Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis

Abnormal uterine bleeding (AUB) is the main symptom of endometrial cancer (EC), but it is highly nonspecific. This represents a huge burden for women's health, since all women presenting with bleeding will undergo sequential invasive tests, avoidable in 90-95% of those women who do not have EC....

Descripción completa

Detalles Bibliográficos
Autores: Martinez-Garcia, Elena|||0000-0003-2547-7916, Coll de la Rubia, Eva|||0000-0001-6709-7554, Lesur, Antoine, Dittmar, Gunnar|||0000-0003-3647-8623, Gil-Moreno, Antonio|||0000-0003-1106-5590, Cabrera Díaz, Silvia|||0000-0002-3164-6686, Colás Ortega, Eva|||0000-0003-0302-4828
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:273357
Acceso en línea:https://ddd.uab.cat/record/273357
https://dx.doi.org/urn:doi:10.3390/cancers15030911
Access Level:acceso abierto
Palabra clave:Carcinoma of the endometrium
Endometrial cancer
Uterine cancer
Biomarker
Diagnosis
Gynecology
Endometrial sampling
Proteomics
Cervical sample
Protein
Non-invasive
Descripción
Sumario:Abnormal uterine bleeding (AUB) is the main symptom of endometrial cancer (EC), but it is highly nonspecific. This represents a huge burden for women's health, since all women presenting with bleeding will undergo sequential invasive tests, avoidable in 90-95% of those women who do not have EC. This study aimed to evaluate the potential of cervical samples collected with five different devices as a source of EC diagnostic protein biomarkers. Samples collected with a Rovers Cervex Brush ® and the HC2 DNA collection device, Digene, were the most suitable for EC proteomic studies. A clinical retrospective study assessing the expression of 52 EC-related proteins in 41 patients (22 EC; 19 non-EC), by targeted proteomics, identified SERPINH1, VIM, TAGLN, PPIA, CSE1L, and CTNNB1 as potential EC protein biomarkers in cervical fluids (AUC.